chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle aches; headaches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle aches) and HEADACHE (headaches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0315M20A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle aches) and HEADACHE (headaches). At the time of the report, MYALGIA (muscle aches) and HEADACHE (headaches) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication information was provided.  No treatment products information was provided.
I got the vaccine in the morning.  That night I was unable to fall asleep the whole night.  A few weeks went by and then I started experiencing occasional insomnia.  I would wake up in the middle of the night and be unable to go back to sleep.  It kept getting worse such that I could not fall asleep without taking a sleeping pill.  What happens is that when I lay down after about 10 to 15 minutes I start to feel a surge of energy.  My body gets hot.  It is not a fever.  My heart seems to beat faster and my mind is racing.  My doctor prescribed both Ambien and Lunesta.   I take one or the other and eventually I go to sleep.  I am averaging about 4 hours of sleep at night after I take the drug.   The stress of not being able to sleep well has given me some anxiety issues.  In addition, the anxiety has led me to develop high blood pressure.   I am now taking high blood pressure medicine.   I am not the kind of person who has anxiety normally.   I believe the vaccine introduced something into my system that is triggered every night now preventing me from natural sleep.
My tongue went tingly like with novocaine and then numb and it traveled down my left side to my toes.  They thought I was possibly having a stroke.  There were tendrils of tingly feeling onto my right side in my tongue and tingles in toes but not nearly the numbness that my left side experienced.
After receiving the vax I ended up going to the er for a really bad headache. They gave me meds for the headache and I was sent home. Was told to take Tylenol and Benadryl till it went away. It last 3 to 4 days. Then yesterday I got up and noticed my tongue was half numb. With in an hour of that my eye started watering when I asked my wife to look at my eye she noticed my face was drooping on my right side. I then went to the ER and they diagnosed me with Bell's Palsy. You have my permission to contact the Facility for any and all other tests done related to this issue.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 02-FEB-2013, pharmacist had attempted to vaccinate the patient with a dose of ZOSTAVAX (lot number, expiry date, route and dose were not reported) and a large amount of the vaccine leaked out between the barrel of the syringe and the needle. The pharmacist also reported that the patient had reported an after hours adverse event. Action taken with the ZOSTAVAX was not applicable. The outcome of after hours adverse event was unknown. Additional information has been requested.
This spontaneous report as received from a healthcare worker (also reported as Healthcare Prof-other) refers to a patient of unknown age and gender. On 03-JUN-2015 the patient was vaccinated with an improperly stored dose of VAQTA 25/0.5, injection (lot # K018181, expiry date 04-JUN-2017) (route, dosing regimen and frequency unknown) for an unknown indication. No concomitant medications were reported. No adverse events were reported. There was no product quality complaint reported. The action taken with the therapy with VAQTA was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with VAQTA. This is one of the many reports form the same source. Additional information has been requested.
Migraine that lasted for 27 hours. Migraine symptoms included severe headache with throbbing pain, nausea, sensitivity to light & sound & smell. Had to remain in bed for the full 27 hours.
Woke up for work around 6 AM and noticed a dull throbbing sensation around the injection site, like a muscle cramp.  The next day it began to spread and by the Friday 11/21/2014 morning my shoulder, neck, and arm were aching, felt like a cramp.  The muscle in my bicep was tense.  This morning, 11/25/2014 I noticed my index and middle finger tips were numb-ish on the same arm I got the shot. I could feel pain if I poked it with a needle or bit my finger tip but pressing on a hard surface left me with no sensation. That arm is also very weak. I was advised to submit this report by my company's employee health dept. The pain is still there as of submitting this report.
Childbirth - first pregnancy, full term delivery at 39 weeks 2 days gestation on May 13, 2022, birth weight 7lbs 7oz, length 20.5in, head circumference 34cm.
Received first dose of PFIZER 10/27/21. Within five minutes of first dose she was vomiting. States she then became dizzy on the way home and vomited again. She has had severe headaches since the vaccine as well. Was seen at Clinic 10/29/21 due to vomiting, headache, blood in urine, and right leg pain. Urine testing was negative for UTI and kidney stone. Leg ultrasound was negative for clot. D dimer was elevated. COVID test was negative. Was seen again in clinic 11/3/21. Given steroids and a Toradol injection for ongoing headache. Has follow up appointment 11/5/21 and will likely do MRI due to ongoing headache. May do ABI due to ongoing leg pain as well. States today is the first day since being vaccinated that she has not had a headache.
Received 2 doses 2 months apart; A spontaneous report was received from a consumer (Nurse) concerning a 29 -year old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) received second dose of Moderna COVID-19 vaccine two months apart.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 01 Mar 2021, the patient received her second of two planned doses of mRNA-1273(Batch Number: Unknown) in left arm for prophylaxis of COVID-19 infection.  On 01 Mar 2021, the patient received second dose of Moderna COVID-19 vaccine two months apart (Inappropriate schedule of vaccine administered).  No treatment information was provided.  Action taken with mRNA-1273 in response to the event received second dose of Moderna COVID-19 vaccine two months apart was not applicable.  The outcome of the event received second dose of Moderna COVID-19 vaccine two months apart was considered recovered.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated AEs reported.
On Friday, 1/21/2022, patient came to the Covid-19 vaccination site for his first Covid-19 Pfizer dose. During administration of vaccine, RN inserted needle in client's left arm and immediately after insertion client pulled his arm away. No vaccine was given to the client at this time. RN explained to client's Mother what happened and she verbally agreed for her son to receive his Pfizer Covid-19 first dose with a new needle. Client was vaccinated with  Pfizer (Lot #: FL0007) at 10:49 PM in his left deltoid. RN let Lead RN know and Lead Operations Lead was made aware of situation via text. Client's Mother denied any underlying medical conditions or allergic reactions and was to be a 15 minute observation. Client's Mother was also educated by RN on signs and symptoms of adverse reactions and when to go to the ED/call MD. Client experienced no adverse reaction while waiting in Observation Area and left vaccination site with a steady gait at approximately 11:15 AM.
This spontaneous report was received from a non health professional (query pending) concerning a 69 year old female patient with no drug reactions/allergies. On 05-NOV-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiration date, dose, route unspecified). Concomitant medication included 10 milligrams (mg) LIPITOR. Normally the patient had a blood pressure of 110-115 (units unspecified). On 14-NOV-2012 (reported as when she went to the doctor's office a few weeks after receiving the shot), she had high blood pressure of 143 (units unspecified). The patient did not seek any medical attention. No treatment was provided. The outcome of high blood pressure was unknown. No lab studies were performed. Additional information has been requested.
Received PEDIARIX, PEDVAX-HIB, ROTATEQ & PCV13, one hr after receiving vaccines developed a rash at the injection sites. OV 10-13-11 with rash: erythematous maculopapular rash both legs (upper ant. thighs) pinpoint in size, with few starting on (L) shoulder & neck. Sleeping more than usual & more fussy. Mom indicates same rash occurred with 2mo vacs. A similar rash of red bumps, started on legs, spread to abd, face & back, did not bother him, lasted 10 days.
During the evening on the day after my 2nd dose I experienced a fever up to 100.9 and when I woke up the following morning my arm was more than sore like the day before.  I softball size raised red spot surrounded the injection site (slight off center, a bit lower where the injection site is more at the top of the softball sized spot).  The injection site was very itchy, and the large red spot was hard, raised, and itchy.  I looked up what this was and saw that is was extremely similar to "COVID Arm" and saw that is was atypical, but ok and that it should go away in a couple days to weeks.  Which it did, at this point I feel a slight sore tingle around the injection site, but no more red spot or itchiness.
I started feeling really bad and got a very severe headache. I called my PCP that morning because my chest felt tight. I went to pharmacy to pick up the prescription but on the way got to the point where I couldn't breathe so I went to ER. They gave me a steroid shot, updraft.  They called in an antiviral, prednisone; inhaler.  The asthma lasted a couple of days but within 6 hours of the antiviral the head and body ache went away.  I went to the Dr. yesterday and now I have an sinus infection and I am still bringing up an outrageous amount of mucus.
Inflamation in upper arm and shoulder- red and hot to touch, cold sweats, low grade fever, severe weakness in legs - difficulty walking, nausea
Localized pain in arm for 2 days after first shot COVID-19 vaccine; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2021US086450_NS (Novartis Pharmaceuticals Corporation).  A 72 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 72 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Localized pain in arm for 2 days after first shot COVID-19 vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2014, the patient was inoculated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, the very virus the ZOSTAVAX vaccine was intended to prevent. In 2015, the patient was treated at a dermatology facility for symptoms of a blistering vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Arm very sore for more over a week Short-term memory loss Mind cloudiness Stomach swelling a week after second shot Digestive track inflammation  Difficulty eating solid foods
I experienced soreness in my left arm, tiredness, pain in my left lymph node and soreness in my neck.
Initial report received from a healthcare professional on 4 October 2013. A patient received FLUZONE (lot # UH920AC, expiration date unknown) intramuscularly at left deltoid on 04-Oct-2013. After vaccination, on 04-Oct-2013 the patient experienced metallic taste in mouth. The patient did not recover from the event. Documents held by sender: none.
feeling cold; running a fever 101.7; Headache; her muscles are seizing; she couldn't move her arms; muscles have gotten tired so she is a little sore; muscles have gotten tired so she is a little sore; seizures; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 52-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6199) via an unspecified route of administration in left upper arm on 16Mar2021 at 15:10 (at the age of 52-years-old) at a single dose for covid-19 immunization. Relevant medical history included typical soreness. She says her son has sensitivity to vaccines. But she only ever has like typical soreness and stuff but normally she goes through fine. She went through the first dose of the vaccine fine. Patient's concomitant medications were not reported. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6200) administered on an unspecified date via an unspecified route. No prior vaccinations within 4 weeks were received. Patient reported that she had the second one yesterday and she is having some symptoms. It started with a headache, then running a fever of 101.7 on 17Mar2021. The things she is concerned about and she has been making all these calls about this morning is her muscles are seizing, like her whole body, down her back and derriere and her legs seize up and become like a board, it does not hurt but after a while she guesses her muscles have gotten tired so she is a little sore but it is not like a horse, her muscles just seize up, she couldn't move her arms on 17Mar2021. Its happened several times. She wanted to report it and make sure this is within the norm or if she should be going further with it. The headache started during the night, she says it was after midnight so 17Mar2021. It is ongoing but much less. Last night it was horrible, she confirms ongoing but improved. Her fever is ongoing at this time it is going up. Started out at 100.6 now it is 101.7, that also began 17Mar2021. It is getting worse. Her seizing muscles she noticed that at about 1 AM this morning so 17Mar2021 as well. It is ongoing but seems to be lessened. There is more time in between them. It was every hour but right now it is happening every 2-2.5 hours so it is improving. Patient stated that during the night/early this morning patient began experiencing feeling cold, seizures (undiagnosed.  Muscle involvement), She explains seizures as not brain related, neck down to my leg, Tighten up. Hold for 10-15 seconds. Flatten out like a board, then it'll go away. Vaccination Facility Type was Hospital. No history of all previous immunization with the Pfizer vaccine. Additional Vaccines Administered on same date of the Pfizer Suspect was none. Adverse events do not require a visit to Emergency Room or Physician Office. The outcome of the events seizure, feeling cold, myalgia, muscle discomfort and limb discomfort were unknown, while for headache and muscle disorder was recovering and for fever was not recovered.
varicellaform rash 1wk p/vax;no pruritus;vesicles more papular;
This spontaneous report as received from a consumer refers to a female patient of unknown age reporting on herself. Pertinent medical history, drug reaction or allergies were not reported. On approximately May 2014, reported as "a week and half ago", the patient was vaccinated with ZOSTAVAX dose 1 (route and lot # were not reported). Concomitant therapy was not reported. In approximately 2014, the patient's arm was sore. The outcome of arm was sore was unknown. Causality was not reported. Additional information is not expected.
Fever started about 5:00pm and lasted 24 hours.  Started feeling drowsy about 4 hours after the vaccine.   I slept for about 2 days and couldn't stay awake.   Headache  started that evening.   I still have the headache  3 weeks later with no relief.   My right cheek and gums hurt so bad too.
Information has been received from a pharmacist referring to a female patient of unknown age. The patient's pertinent medical history included celiac disease. The patient had no drug reactions/allergies. Concomitant medication was unknown. On 10-NOV-2016, the patient was vaccinated with (Oka/Merck) VARIVAX (lot # M023384, expiration date 11-MAY-2018; dose and route were unknown. On 11-NOV-2016, the patient experienced injection site redness, warm to touch and felt hard. Also, the pharmacist stated that the patient stated that the diameter of the injection site looked like it was getting larger by the day. The patient went to Urgent Care on 12-NOV-2016 and was given antibiotics as a treatment for the adverse effects. The outcome of the events was reported as not recovered. The causality assessment was not provided. Additional information has been requested.
Pt. states on 12-14-09, that she's "had a reaction to her H1N1 vaccine". First she "had extreme pain in her femurs and fib..fibs". She didn't report it right away because she "has a lot of arthritic issues" then she had increasing problems walking. She describes it as lurching" last weekend she fell over backwards in her closet. Referred to her PCP immediately. 12-17-09 pt called to say Dr told her Dx - GUILLAIN-BARRE-Syndrome.  12/18/09 PCP medical records received. Service date 12/14/09. Assessment: Muscle Weakness. Patient presents with leg/hip pain. Trouble walking and has fallen. Paresthesias in legs followed by bone pain. Referred to neurologist.
FIBROMYALGIA; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 21-SEP-2021) dose was not reported, administered on 27-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On MAY-2021, the patient experienced fibromyalgia. Laboratory data (dates unspecified) included: Blood test (NR: not provided) No significant findings. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fibromyalgia. This report was non-serious.
inflammation and swelling at the injection site; Initial information received on 05-Jun-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to cases 2019SA157325, 2019SA157349 and 2019SA157350.  This case involves a 51 years old female patient who experienced inflammation and swelling at the injection site, while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 03-May-2019, the patient received a first  dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot C5609AA (Expiry date 04-Apr-2021) via intramuscular route in the right deltoid.  On an unknown date, the patient developed a non-serious inflammation and swelling at the injection site (vaccination site inflammation) (Unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was inflammation and swelling at the injection site.   It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for inflammation and swelling at the injection site.  Information on the batch number was requested.  List of documents held by sender: none.
arm felt dead at times, then felt  pain running through arm brought tears to her eyes, severe pain  swollen,  painful to the touch throught she was having a stroke
BREATHROUGH COVID: PT FULLY VACCINATED,  BOOSTED, HX OF COVID 2019:  78YO FEMALE ADMITTED WTIH COVID 19 POSTIVE AT SNF, FEVER, HYPOXIA, UTI, DEMENTIA, COAGULASE-NEGATIVE STAPHYLOCCAL BACTEREMIA (SUSPECT CONTAMINANT).  TREATMENT FOR COVID WITH REMDESIVIR, COMPLETED ZOSYN, AND PO STEROIDS.
I experienced a on my skin 2" below the site where the vaccine a previous scar became itchy and there was a red bump in the middle of it. I went to my Dermatologist who froze the area off from where I previously had Squamous Cell Cancer. Afterwards, the area still has a light faint red spot on my upper arm that no longer itches. I am scheduled to see my Dermatologist every 6 months to check the area as a precaution to make sure that it does not flare up or start itching again.
Shortness of breath, wheezing 4 hours after vaccination. IV-Solumedrol, Benadryl
Information has been received on 9/9/03 from a physician concerning an employee's child who was vaccinated about two weeks ago on approximately 8/26/03, with a dose of MMR (second generation) (lot not available). Subsequently the patient developed Henoch-Schonlein purpura. Medical attention was sought. The physician may not be contacted and did not have any additional information to provide. Upon internal review, Henoch-Schonlein purpura was determined to be an other important medical event (OMIC). No further information is available.
take the 2nd IMOVAX vaccine 2 weeks after the scheduled dose with no reported adverse event; Initial information received on 27-May-2022 regarding an unsolicited valid non-serious case received via other health professional.  This case involves an unknown age male patient who experienced take the 2nd imovax vaccine 2 weeks after the scheduled dose with no reported adverse event while receiving vaccine rabies (hdc) vaccine (Imovax Rabies).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 19-May-2022, the patient received a dose of suspect rabies (hdc) vaccine lot U1D221M (dose, route and administration site: unknown) for Immunization.  It was stated that patient had the 1st rabies (hdc) vaccine on 19-May-2022. The patient was due for the 2nd dose of rabies (hdc) vaccine today, 27-May-2022, however the pharmacist stated that the rabies (hdc) vaccine will not be available until approximately 2 weeks from now. She asks it acceptable to take the 2nd rabies (hdc) vaccine 2 weeks after the scheduled dose (off label use) (unknown latency).  Action taken: not applicable.  Outcome was Unknown